What is it about?
My study investigates how tiny drug delivery vehicles, specifically layered double hydroxide (LDH) nanoparticles, travel inside the two main types of nerve cell branches: axons and dendrites. LDH nanoparticles are promising nanocarriers used to deliver therapeutic genetic material, such as small interfering RNAs (siRNAs), to destroy harmful proteins responsible for neurodegenerative conditions like Huntington's disease. Using transport equations based on reaction-diffusion-convection principles, I modeled how these nanoparticle-loaded vesicles move through a combination of active transport powered by dynein molecular motors and passive diffusion. The model accounts for fundamental structural differences between axons and dendrites. In axons, nanoparticles enter exclusively at the terminal ends, and the internal microtubule tracks are uniformly oriented, allowing dynein motors to pull vesicles smoothly toward the cell body. In contrast, dendrites internalize nanoparticles across their entire outer surface and feature mixed microtubule orientations near the cell body. My mathematical simulations reveal that if transport in dendrites relies solely on dynein motors, nanoparticles accumulate at the boundary where microtubule alignment shifts, creating an intracellular traffic bottleneck.
Featured Image
Photo by Shubham Dhage on Unsplash
Why is it important?
Delivering therapeutic agents directly to brain tissue is one of the greatest challenges in medicine because the blood-brain barrier blocks most conventional medications. Biocompatible nanoparticles offer a breakthrough solution by penetrating cellular barriers and delivering targeted treatments to affected neurons. However, designing effective therapies requires understanding how nanoparticles behave once inside the cell, as trapped or misdirected particles cannot deliver their genetic cargo to the cytoplasm effectively. This research provides a critical theoretical foundation that bridges mathematical modeling and experimental neurobiology. By demonstrating that dynein transport alone would cause nanoparticles to pile up at microtubule transition zones in dendrites, my work alerts researchers to additional mechanisms—such as kinesin motor involvement or structural adaptations—that cells must use to keep cargo moving. Furthermore, showing that nanoparticle flux increases toward the cell body in dendrites due to continuous membrane uptake helps experimentalists optimize dosage and entry points for neurodegenerative disease therapies.
Perspectives
Developing this mathematical model was an exciting endeavor at the intersection of mechanical engineering, transport phenomena, and neurobiology. Applying partial differential equations to capture the microscopic journey of nanoparticles along cellular highways allowed me to uncover physical insights that are difficult to observe through live-cell imaging alone. It was particularly gratifying to see how physical mass-balance principles could explain potential intracellular congestion and guide future biological testing. I hope this paper demonstrates the immense power of computational modeling in accelerating medical research and refining drug delivery designs. By providing physical boundaries and predictive metrics for intracellular nanoparticle traffic, I hope to inspire closer collaboration between bioengineers and neuroscientists in creating targeted therapies for brain disorders. Ultimately, making these abstract transport processes clear and actionable brings us one step closer to practical treatments for patients.
Andrey V Kuznetsov
North Carolina State University
Read the Original
This page is a summary of: Modelling transport of layered double hydroxide nanoparticles in axons and dendrites of cortical neurons, Computer Methods in Biomechanics & Biomedical Engineering, December 2012, Taylor & Francis,
DOI: 10.1080/10255842.2011.585977.
You can read the full text:
Contributors
The following have contributed to this page
